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Abstract
Backgrounds: Exposure to nanoparticles in the workplace is a health concern to occupational workers with
increased risk of developing respiratory, cardiovascular, and neurological disorders. Based on animal inhalation study
and human lung tumor risk extrapolation, current authoritative recommendations on exposure limits are either on
total mass or number concentrations. Effects of particle size distribution and the implication to regional airway
dosages are not elaborated.
Methods: Real time production of particle concentration and size distribution in the range from 5.52 to 98.2 nm
were recorded in a wire-cut electrical discharge machine shop (WEDM) during a typical working day. Under the
realistic exposure condition, human inhalation simulations were performed in a physiologically realistic nasal and
upper airway replica. The combined experimental and numerical study is the first to establish a realistic exposure
condition, and under which, detailed dose metric studies can be performed. In addition to mass concentration guided
exposure limit, inhalation risks to nano-pollutant were reexamined accounting for the actual particle size distribution
and deposition statistics. Detailed dosimetries of the inhaled nano-pollutants in human nasal and upper airways with
respect to particle number, mass and surface area were discussed, and empirical equations were developed.
Results: An astonishing enhancement of human airway dosages were detected by current combined experimental and
numerical study in the WEDM machine shop. Up to 33 folds in mass, 27 folds in surface area and 8 folds in number
dosages were detected during working hours in comparison to the background dosimetry measured at midnight.
The real time particle concentration measurement showed substantial emission of nano-pollutants by WEDM machining
activity, and the combined experimental and numerical study provided extraordinary details on human inhalation
dosimetry. It was found out that human inhalation dosimetry was extremely sensitive to real time particle concentration
and size distribution. Averaged particle concentration over 24-h period will inevitably misrepresent the sensible
information critical for realistic inhalation risk assessment.
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Conclusions: Particle size distribution carries very important information in determining human airway dosimetry. A
pure number or mass concentration recommendation on the exposure limit at workplace is insufficient. A particle size
distribution, together with the deposition equations, is critical to recognize the actual exposure risks. In addition,
human airway dosimetry in number, mass and surface area varies significantly. A complete inhalation risk assessment
requires the knowledge of toxicity mechanisms in response to each individual metric. Further improvements in these
areas are needed.
Keywords: Inhalation toxicity, Nanoparticles, Human upper airways, Particle dosimetry, Particle size distribution,
Computational fluid dynamics (CFD),
Background
Exposure to nanoparticles in the workplace is a health
concern to occupational workers where there is an
increased risk of developing respiratory, cardiovascular,
and neurological disorders [1]. Confirmed inhalation
hazards include the notorious asbestos, with low dosage,
causing severe health consequences [2]. The onset of
“manganism”, a clinical diagnosed neuro-toxin caused by
high level exposure to manganese containing particles,
were reported in occupational workers conducting min-
ing, ore grinding and smelting activities [3, 4]. In addition
to confirmed cases, there have been discussions on the
link between sub-clinical human functional impairment
and chronic low dose metal particle exposures [5–7].
Similar concerns were also reported in the office environ-
ment where the increased usage of modern electrophotog-
raphy machines elevates the health risks of office workers
on inhalation exposure to the emitted nanoparticles
during xerographic processes [8, 9]. Electrical discharge
machining (EDM) is one of the most important manufac-
turing processes in the die and mold industry for delicate
concave shapes which traditional machining cannot
achieve [10]. Rather than using mechanical forces, EDM
utilizes high voltage between the “wire” electrode and the
conductive metal piece to cause high energy sparks which
remove the material by melting and erosion. This high
energy electrophysical process is more likely to generate
pollutant by-product in nanoscale [11].
Based on animal inhalation study and human lung
tumor risk extrapolation, National Institute for Occupa-
tional Safety and Health (NIOSH, USA) [12] recom-
mended exposure limits to fine (diameter > 0.1 μm) and
ultrafine (diameter ≤ 0.1 μm) titanium dioxide particles
as 2.4 mg/m3 and 0.3 mg/m3 in normal working condi-
tions. German Institute for Occupational Safety and
Health of the German Social Accident Insurance (IFA)
[13] established the benchmark limits for ultrafine par-
ticle concentrations in workplaces based on state of the
art knowledge of measurement and exposure risks. It
states that, for ultrafine (1 to 100 nm) metal, metal oxide
and other biopersistent granular nanomaterials with a
density > 6000 kg/m3, a particle number concentration
of 20,000 particles/cm3 should not be exceeded. For
ultrafine particles with a density below 6000 kg/m3, a par-
ticle number concentration below 40,000 particles/cm3
should be imposed. Other recommendations include
10 mg/m3 by American Conference of Governmental
Industrial Hygienists (ACGIH) [14] and 15 mg/m3 by the
Occupational Safety and Health Administration (OSHA,
USA) [15] for total inhalable particles (diameter ≤ 100 μm).
For respirable particles that can penetrate to the alveolar
region (diameter ≤ 10 μm), ACGIH and OSHA refine the
exposure limit to 3 and 5 mg/m3 respectively [12]. In sum-
mary, current exposure standards are focused on ultrafine
nanoparticles of 1 to 100 nm, and the recommendations
are either on the total mass or number concentrations.
Effects of the particle size distribution and the implication
to regional airway dosages are not elaborated.
In addition to animal and experimental studies, com-
putational fluid dynamics (CFD) are frequently used for
investigating detailed human inhalation and particulate
transport processes. Compared to experiments, com-
puter simulations are significantly less restrictive from
time, cost and ethical perspectives. It allows decompos-
ition of the complex physical phenomenon into focused
areas where details of the particle-pulmonary interac-
tions can be derived and integrated. Respiratory anat-
omy, airflow and particle transport and deposition are
the main focused areas where a broad range of CFD
studies were reported in past 2 decades. Heistracher and
Hofmann (1995) proposed a physiologically realistic
human bronchial airway bifurcation model [16]. Tian
and Ahmadi (2012) extended the model for multi-level
bronchial bifurcations where entire lung can be con-
structed sequentially [17]. For nasal airways, Zamankhan
et al. (2006) and Inthavong et al. (2009) presented meth-
odology of reconstructing human nasal cavities from
casts and CT scans respectively [18, 19]. Detailed flow
patterns and particle transport characteristics around
the human body can be found in the work of Kennedy
and Hinds (2002), Anthony and Flynn (2006), Se et al.
(2010), Inthavong et al. (2012, 2013), and Ghalati et al.
(2012) [20–25]. Inside the human respiratory system,
Katz and Martonen (1996), Zhang and Kleinstreuer
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(2001), Hofmann et al. (2003), Tian and Ahmadi (2012,
2013), and Inthavong et al. (2010) [17, 26–29] employed
computational models to investigate the airflow, and
particle transport and deposition in human tracheobron-
chial airways. Subramaniam et al. (1998), Matida et al.
(2003), Zamankhan et al. (2006), Xi and Longest (2008),
Inthavong et al. (2011), Ge et al. (2012) and Tian et al.
(2016) [18, 30–35] applied CFD methods in the human
nasal/head airways for airflow and particle transport
analysis. To evaluate the influence of breathing pattern
on particle deposition, Häuβermann et al. (2002) and
Inthavong et al. (2010) performed particle transport
modeling in nasal and tracheobronchial airways respect-
ively [36, 37]. CFD also plays important role in the study
of non-spherical particle transport behavior in human
airways. Tian et al. (2013, 2016), Inthavong et al. (2008),
and Dastan et al. (2013) were among the few who
investigated fibrous and agglomerated particle deposition
in human nasal and tracheobronchial airways using
CFD-DPM method [29, 34, 53, 38–40]. Recently, CFD-
DEM has gained growing interest in studying non-
spherical particle dynamics [41]. It has the potential to
be applied in human inhalation study. These computa-
tional investigations provide detailed descriptions of
flow and particle features and allow wider coverage of
flow and particle conditions, which would otherwise be
difficult to infer from experimental measurements.
While most of the computational analysis provides valu-
able information on detailed flow pattern, particle trajec-
tories and deposition statistics, there has been no study
incorporating a realistic inhalation profile accounting for
exposure to particle size distribution to inhaled dosimetry.
In this research, a combined experimental and numerical
study in the upper airway dosimetry of ultrafine particles
in an electrical discharge machine shop was performed.
The real time evolution of particle concentration and size
distribution in the range from 5.52 to 98.2 nm during
normal operation of electrical discharge machining was
measured during a typical working day. Under these
conditions, human inhalation simulations were performed
in a physiologically realistic nasal and upper airway
replica. Respiratory health risk was determined by regional
dosimtries in context of exposure limits recommended by
NIOSH, ACGIH, OSHA and IFA. In addition, dose metric
relationships with respect to particle number, mass and
surface area were analyzed. Based on the simulation data,
empirical equations were developed to predict the local
dosimetry of the inhaled nanoparticles in human nasal,
laryngeal and deeper airways. The combined experimental
and numerical study is the first to establish a realistic
exposure condition, and under which, detailed dose metric
studies were performed. The developed empirical
equations will be useful for future nanoparticle dose-
deposition prediction in inhalation risk assessments.
Methods
Particle measurement in an electrical discharge machine
shop
Located in Beijing, China, the 3.8 m high machine shop
hosts five wire-cut electrical discharge machineries
(WEDM) manufacturing hardened metal pieces of desired
shape during regular working hours (Fig. 1) (WEDM#1-
Beijing AgieCharmills Industrial Electronics FW2;
WEDM#2 and #3 – Shanghai Troop Group Photoelectric
Technology TP-25ZT and TP3271; WEDM#5-Beijing
Ninva NH7120ND; WEDM#4 – out of service). The high
voltage between the “wire” electrode and the conductive
metal piece causes high energy sparks which remove the
material by melting and eroding processes. A dielectric
liquid (DIC-206, Beijing Hua Ye Oil Limited, China) was
used to flush out particle debris as well as restore the
electrode potentials. Particle measurements took place
during normal working hours from 8:00 to 17:30 in
winter. Due to the cold weather condition, window in the
machine shop was closed during the working hours, how-
ever left open overnight. The door was normally closed
with occasional opening by the single machine operator
during breaks, including a regular lunch break from 12:00
to 13:30. There was no mechanical ventilation in the
workshop and no personal protective equipment was used
by the operator due to minimal visible fume emission.
The sampling station was located in the breathing zone
about 1.5 m high and 1.2 to 5.0 m away from the electrical
discharge machines.
The sampling station hosts a suite of aerosol instru-
ments, and the ultrafine particle concentration was
measured by a Scanning Mobility Particle Sizer (SMPS,
TSI Model 3936, USA), consisting of a Water-Based
Condensation Particle Counter (CPC, TSI Model 3788,
USA), an Electrostatic Classifier (EC, TSI Model 3080,
USA), a Nano Differential Mobility Analyzers (DMA,
TSI Model 3085, USA) and a long DMA (TSI Model
3081, USA). Both the Nano and long DMAs detect par-
ticles up to 108 particles/cm3 in real time, with a range
from 2 to 100 nm, and 14 to 675 nm respectively.
Larger particles >1 μm were eliminated by a pre-
conditioner impactor at a setting of 0.0457 cm. The
DMA Sheath Flow was 7 L/min. Before each field
measurement, “zero” calibration was conducted by
using a high efficiency particular air filter (HEPA). A
diffusion loss correction was applied to account for the
nanoparticle losses in the sample lines based on previously
described method [42]. In addition to the particle concen-
tration instrumentation, a Micro-Orifice Uniform-Deposit
Step Size Impactors (MOUDI, Model 125B NanoMoudi-
II, MSP Corporation, USA) was used to collect aerosol
particle samples for morphology analysis. The airborne
particles were captured on the polycarbonate filters
(Φ 47 mm, 0.22 μ, Munktell Inc., Sweden), 2 Scanning
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Electron Microscopic (SEM) wafers (4 mm × 4 mm,
Zhongxing Bairui Inc., China), and 2 Transmission elec-
tron microscopy (TEM) grids (200-mesh molybdenum
with carbon film, Zhongxing Bairui Inc., China) at a
steady flow rate of 10 L/min by using a vacuum pump
(Sogevac SV10-16 B, Leybold Vacuum GmbH Co., Ltd.,
Germany). Offline examination of the wafer was performed
with SEM (S-4800 N, HITACHI Inc., Japan). Further detail
of the WEDM measurement was given in [43].
Human nasal and upper respiratory airway Modeling
A CFD model of the upper respiratory airway containing
facial features, the nasal cavity, larynx, trachea and first
bifurcation of the bronchial airway tree was developed
from CT scans [36, 44, 45] (Fig. 2). Each model of the
respiratory airway was connected to form a contiguous
path via nostrils, from the external space to the end of
the larynx region. The larynx region was extended to the
first lung bifurcation to allow sufficient flow recovery
and improve numerical convergence in the CFD solu-
tion. The respiratory airway was added to a realistic
human face exposed to the external surroundings con-
taining airborne particles from the electrical machine
shop. Shang et al. (2015) [45] showed that the airflow
has negligible influence on particle trajectory outside the
breathing zone. In this study, particles were uniformly
released on a hemisphere (of radius 3 cm) with the cen-
ter at the nose tip, resembling the release condition of
Doorly et al. (2008) [46]. A high quality mesh (minimum
orthogonality >0.1) incorporating prism layers was applied
to the bounding respiratory walls, and tetrahedral unstruc-
tured mesh filled the airway passage. The final model is
shown in Fig. 2, which consists of 7 million cells. Further
detail of the computational model was given in [22].
Fluid flow simulation
The current study employed a steady inhalation model
with the assumption that particle deposition mainly
occurs during the inhalation phase [36]. It is worth to
note that breathing pattern was shown to affect depos-
ition for micron range particles between 1 and 5 μm
[37], however, the effect toward nanoparticle deposition
was still not fully understood and requires further inves-
tigation. Mild cardiac load was assumed as the machine
operator was mainly standing with occasional walking to
attend the metal pieces. Laminar flow condition was con-
sidered and inspiration flow rates from 3 to 15 L/min were
Fig. 1 Floor plan of the WEDM machine shop (dimensions not to scale)
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included. The wide coverage of the breathing rates is to
facilitate the development of the empirical equations.
The airflow was simulated using Ansys-Fluent v16.2.
The surrounding walls were set to atmospheric pressure
and inhalation was initiated by a negative pressure
difference at the bronchial bifurcation outlet. This
allowed the ambient flow field to be influenced only by
the inhaled air. The continuity and momentum equation
of the fluid flow are:
∂
∂xi
ρuið Þ ¼ 0; ð1Þ
ρuj
∂ui
∂xj
¼ − ∂p
∂xi
þ ∂
∂xj
μ
∂ui
∂xj
 
: ð2Þ
where ρ, u and p are density, velocity and pressure of
the air, respectively. A second order upwind scheme
was used to approximate the momentum equation,
while the pressure–velocity coupling was handled
through the SIMPLE method. Further detail of the fluid
flow modeling was given in [47].
Particle simulation
The Lagrangian particle tracking method is used where
each particle’s trajectory is computed. The particle
equation is:
dup
dt
¼ 1
Cc
FD þ
g ρp−ρ
 
ρp
þ FL þ FB ð3Þ
here up is the particle velocity, t is the time, g is the
gravitational constant, ρp is the particle density. In this
study, both gravitational and buoyancy forces can be
neglected. FD is the drag force given by 18 μ(upu)/
(d2ρp), here d is the particle diameter. Cc in Eq. (3) is the
Cunningham correction given by:
Cc ¼ 1þ 2λd 1:257þ 0:4e
−1:1d=2λð Þ
 
; ð4Þ
λ is the molecular mean free path. FL in Eq. (3) is the
Saffman lift force, and FB is the Brownian diffusion force
with amplitude of ζ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
πS0=Δt
p
, here ς is a zero mean, unit
variance independent Gaussian random numbers. Δt is
the time-step for particle integration and So is a spectral
intensity function [48]:
:
So ¼ 216νkT
π2ρd5
ρp
ρ
 2
Cc
: ð5Þ
ν is the fluid kinematic viscosity, k is the Boltzmann
constant, and T is the absolute temperature of the
inspiratory air in the nasal cavity. The simulation was
carried out with Ansys-Fluent v16.2 discrete phase
model (DPM).
With the closed window, door and the lack of mech-
anical ventilation during the machining process, a
homogeneous dispersion of the airborne particles was
assumed in the breathing zone. For this study, statisti-
cally independent 100,000 uniform concentrated mono-
dispersed airborne particles for each particle size, in a
hemispheric profile (Fig. 2), were released. Particles of 1,
1.5, 2, 3, 5, 10, 15, 20, 30, 40, 50, 70 and 100 nm were
included in the study. All particles entered the human
nasal airway. Deposition onto the respiratory walls
occurred when the particle was within d/2 distance away
from the surface. Here d was the particle diameter.
Model validation
The particle Eq. (3) was solved by stepwise integration
over discrete time steps yielding a new particle velocity
at each time step. Inthavong et al. (2016) [49] identified
the sensitivity of nanoparticle diffusion behavior in
Lagrangian tracking to the integral time step factor, mesh
size and flow condition. A methodology of selecting the
Fig. 2 Human nasal and upper respiratory airway model
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most appropriate time step factors to achieve optimal La-
grangian tracking outcome was proposed and verified in a
pipe and a human pharynx model [49].
In Ansys-Fluent, the length scale factor of integration,
Ls controls the integration time step size and Δt is a
function of the particle velocity and the continuous
airflow phase velocity:
Δt ¼ Ls
up þ u ð6Þ
This means that the length scale factor is proportional
to the integration time step, equivalent to the distance
that the particle travels before its equations are solved
again and its trajectory updated. A smaller value for the
length scale increases the number of calculations per
distance length. Its selection must reproduce the diffu-
sion dispersion mechanism for nanoparticles [49]. A
standard geometry in the form of a pipe (Fig. 3a) with
analytical solution by Ingham (1975) [50] was used to
validate the particle dispersion. A fully developed flow of
1 L/min and 5 L/min was used which has a correspond-
ing Re = 312, and Re = 1560 respectively. The particles
were introduced into the pipe with a mass flow rate
distributed with a fully developed profile as:
_m rð Þ ¼ ṁ0 1− r
2
R2
 
ð7Þ
where m0is the maximum mass flow rate at the pipe cen-
terline, r is the radial position from the pipe centerline,
and R is the pipe radius. Particle deposition in the pipe
over a distance of 0.09 m was compared with the depos-
ition efficiency (DE) correlation by Ingham (1975) [50].
DE ¼ 1−

0:819e−14:63Δ þ 0:0976e−89:22Δ
þ0:0325e−228Δ þ 0:0509e−125:9Δ2=3

ð8Þ
where
Δ ¼ DLpipe
4U inletR2
ð9Þ
Particle deposition in a pipe length of 0.9 m was
compared for length scale factors of 5e-5 m, 1e-5 m, and
5e6 m, which showed that the deposition was best
described using a value of 1e-5 m. Applying the method
to a human pharynx model with 10 different length scale
factors, an optimal value of 2e-5 m was identified.
Further detail of the methodology was given in [49].
Particle size distribution and concentration
Typical ambient environment contains polydispersed
particles where the number concentration (number of
particles per unit volume) is closely related to the size
distribution n(d, r, t), given as:
dN ¼ n d; r!; t	 
d dð Þ ð10Þ
Here n is the particle size distribution function, r is
the position, t is time and d is the particle diameter. Ac-
cordingly, total number of particles per unit volume can
be obtained as:
N ¼
Z ∞
0
n d; r!; t	 
d dð Þ ð11Þ
Due to emission, migration and particle coagulation, N
in ambient environment is a function of time and space.
In a time domain from t1 to t2, the averaged size distri-
bution function is given as:
Fig. 3 Brownian diffusion validation testing in a pipe geometry. a meshing scheme; b comparison with analytical solution by Ingham (1975) at
pipe flow of 1 L/min; c comparison with analytical solution by Ingham (1975) at pipe flow of 5 L/min
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n d; r!	 
 ¼ 1
t2−t1ð Þ
Z t2
t1
n d; r!; t	 
dt ð12Þ
therefore, the total number of particles per unit volume
in the timeframe can be obtained as:
Nt1‐t2 ¼ t2−t1ð Þ
Z ∞
0
n d; r!	 
d dð Þ
¼ t2−t1ð Þ
Z ∞
0
1
t2−t1ð Þ
Z t2
t1
n d; r!; t	 
dt
 
d dð Þ
ð13Þ
Given size distribution function n(d, r, t) (Eq. 10), particle
surface area, volume and mass concentrations can be
readily obtained if particles are spherical, they are:
dA ¼ πd2 n d; r!; t	 
d dð Þ ð14Þ
dV ¼ π
6
d3 n d; r!; t	 
d dð Þ; ð15Þ
dM ¼ ρp
π
6
d3 n d; r!; t	 
d dð Þ: ð16Þ
Similarly to Eq. (13), the total surface area, volume and
mass of particles per unit volume in the timeframe from
t1 to t2 can be obtained as:
At1‐t2 ¼ t2−t1ð Þ
Z ∞
0
πd2n d; r!	 
d dð Þ
¼ π t2−t1ð Þ
Z ∞
0
1
t2−t1ð Þ
Z t2
t1
d2n d; r!; t	 
dt
 
d dð Þ
ð17Þ
V t1‐t2 ¼ t2−t1ð Þ
Z ∞
0
π
6
d3n d; r!	 
d dð Þ
¼ π
6
t2−t1ð Þ
Z ∞
0
1
t2−t1ð Þ
Z t2
t1
d3n d; r!; t	 
dt
 
d dð Þ
ð18Þ
Mt1‐t2 ¼ t2−t1ð Þ
Z ∞
0
ρp
π
6
d3n d; r!	 
d dð Þ
¼ ρp
π
6
t2−t1ð Þ
Z ∞
0
1
t2−t1ð Þ
Z t2
t1
d3n d; r!; t	 
dt
 
d dð Þ
ð19Þ
Deposition efficiency and particle dosimetry
Particle deposition efficiency (DE) is defined as the ratio
of the deposited particles in a region to the total number
entering to that region; that is:
DE ¼ Number of Deposited Particles
Total Number of Particles Entering to the Region
ð20Þ
It is an important parameter characterizing the regional
filtering capacity and particle penetration rate. Deposition
efficiency (DE) is closely related to the transport mecha-
nisms and for nanoparticles, size, diffusivity and airflow
rate are identified the dominant parameters. Due to
geometric complexity of human airways, no analytical
expression is available for the deposition efficiency (DE).
Frequently, empirical fitted deposition equations are used
to relate measured data (DE) to the governing parameters.
Given particle size distribution and airway deposition
equation, particle dosimetries by number, surface area,
volume and mass can be readily obtained as:
Dosenumber ¼
Zt2
t1
Zd2
d1
n d; r!; t	 
 DEð Þd dð Þdt ð21Þ
Dosesurface area ¼
Zt2
t1
Zd2
d1
πd2n d; r!; t	 
 DEð Þd dð Þdt
ð22Þ
Dosevolume ¼
Zt2
t1
Zd2
d1
π
6
d3n d; r!; t	 
 DEð Þd dð Þdt ð23Þ
Dosemass ¼
Zt2
t1
Zd2
d1
ρp
π
6
d3n d; r!; t	 
 DEð Þd dð Þdt ð24Þ
Here (t1, t2) and (d1, d2) are the time and particle size
range respectively.
Results
Particle morphology
Sample SEM and TEM images of the airborne particles
were shown in Fig. 4. The aerosol particles from the pro-
duction activity were largely less than 100 nm and typic-
ally captured by the filter of size range from 56 nm to
100 nm. A mixture of iron, aluminum, copper, and trace
elements of Mg, Mn, Mo, Zn, Ni, Cr were detected in
particle composition. For simplicity, a particle density of
2700 kg/m3, close to that of aluminum, was assumed in
current numerical simulation. While the larger particles
appear to be compact and closer to spherical shapes, the
smaller ones are more agglomerate-like formed by clus-
ters of smaller sized spheres. Since the bipolar charger
and the particle classification in the SMPS Particle Sizer
utilize both a spherical particle model and an idealized
aggregated mobility model, both will be considered in
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the inhalation study. This study focuses on the method-
ology of the combined study using the spherical
assumption. The effect of agglomeration to particle
measurement and inhalation risks will be investigated
in a subsequent paper.
Particle distribution in the machine shop
Figure 5 shows the measured ultrafine particle (5.52 to
98.2 nm) concentration in the electrical discharge ma-
chine shop during a 24-h period in a typical working
day. The total mass and number concentrations correl-
ate with working hours which start at 8:00 am and end
around 17:30 pm. Particle total mass concentration took
a sharp increase (from 2.25 μg/m3) shortly after 8:00 am,
peaked (at 27 μg/m3) around 9:30 am and maintained
the high level until lunch break. Total mass concentra-
tion decreased steadily during the lunch break and a
minimum value of 4.5 μg/m3 was reached before
13:00 pm. Particle total mass concentration once again
took a sharp increase following the beginning of the
afternoon shift, reaching a high of 29.25 μg/m3 around
14:00 pm, and dropped to 9 μg/m3 around 15:00 pm.
The particle concentration was maintained at this level
until 20:30 pm before it finally dropped to the back-
ground level. A similar trend of variation (from 30,000
to 139,000 particles/cm3) was observed in Fig. 5b for the
ultrafine particle total numbers; however, a persistent
high level of concentration was maintained throughout
the working period and it was less affected by the micro-
activities such as the lunch break. It was seen from Fig. 5
that both the total mass and total number concentrations
for the ultrafine particles in the machine shop correspond
to the production activity. A high particle inhalation
exposure to the machine operator is clearly demonstrated.
To evaluate the evolution of particle size distribution,
Figs. 6 and 7 shows the particle size resolved concentra-
tions at a series of representative high production phases
(9:30 am, 11:00 am and 14:30 pm). Background concen-
tration was assumed at midnight when a minimum and
steady particle concentration was observed. In these
figures, the increase of particle concentration over the
background was presented to allow a focused analysis on
emissions produced by the machining activity. Figure 6a
showed that, across all sized groups, a large number of
particles (in the order of 104 #/cm3) were generated due
to the production. In general, particle number concen-
tration increase was higher in the smaller sized groups
(5–30 nm) than the larger ones (>30 nm). However,
from the percentage increase perspective (Fig. 6b), the
production produced significantly higher number of par-
ticles in the larger size groups (>30 nm), monotonically
related to the particle sizes. Background particle number
concentration was shown in Fig. 6c for comparison.
Figure 6 implied a high level of number presence, in the
background and also in the machine shop during
production, of the ultrafine particles in the lower size
range (<30 nm). Relative to the background, the produc-
tion activity most effectively increased the number of
ultrafine particles in the larger size range (>30 nm).
Contrary to the particle number count, increase of the
particle mass concentration due to production is clearly
positively related to particle size from both absolute and
percentage perspectives (Fig. 7). Mass concentration
increase for the smaller particle size groups was almost
Fig. 4 Sample morphologies of collected airborne particles by
MOUDI 125B in the WEDM machine shop
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negligible (<20 nm). The mass concentration for the
larger particle size groups was monotically increasing
with the particle sizes. Figures 6 and 7 implied that
though particle number was higher for the smaller sizes,
the mass concentration was dominated by the larger
sized groups. The mass increase due to production emis-
sion was predominantly contributed by ultrafine parti-
cles in the larger size range (>50 nm).
Breathing airflow pattern
Light breathing at flow rates of 3 to 12 L/min was
included in the simulation. Corresponding Reynolds
number at the nostrils was given in Table 1. Key features
of the airflow pattern were similar, conforming to the
geometric details of the airway. Figure 8 displayed the
stream-wise and axial airflow pattern in the nasal and
upper airways at selected locations. Ambient air enters
the nostril in an upward direction, and turns 90o enter-
ing the middle and inferior nasal meatus before a second
90° at the posterior nasopharynx. High velocity was
observed at the nostril entrance, downstream of the nasal
valve and at the larynx. Bulk air passes through the middle
and inferior meatus, while the superior meatus that
includes the olfactory region, has very low velocity passing
through. Airflow pattern progresses rapidly in the laryn-
geal region, with high velocity streams shifting from back
to anterior walls implying significant secondary flow along
the airway passage. Since the inhaled airborne particles
are transported by the moving fluid, regions with higher
velocity imply high particle concentrations. The flow pat-
tern provides valuable indication for the potential depos-
ition of the inhaled particles. Airflow changes, such as a
sharp turn, a sudden contraction or an expansion of the
cross sectional area may have profound consequence for
particle depositions.
Particle deposition pattern and deposition equations in
human upper airways
Figure 9 shows sample deposition pattern of the inhaled
nanoparticles (1 and 100 nm) in the nasal cavity and
laryngeal region. Here particle size range is slightly
expanded to allow a wider coverage of the developed
deposition equations being applied in future applications.
To elucidate the obscured region in the 3D domain
(Fig. 9a), a surface mapping technique [51] was applied
where the 3D bounding surface is unwrapped to a 2D
surface and shown in Fig. 9b-d. High deposition was
observed in nasal vestibule, on anterior septum before
the 90° turn, and in posterior nasal cavity following the
second 90° turn. In main nasal cavity, majority of the
deposition occurred in middle meatus. A small fraction
was scattered across superior meatus onto the olfactory
mucosa. The left and right nasal chamber geometries
were asymmetric with the right chamber slightly wider.
Particle deposition pattern was affected by particle size
with significantly more deposition and random distri-
bution observed for 1 nm particles. Sporadic and streak
patterned deposition (in laryngeal region, Fig. 9d) of
the 100 nm particles implied a lower level Brownian
diffusion. The nasal cavity was shown to effectively
filter the 1 nm particles, while 100 nm particles were
more likely to penetrate through and have higher
deposition in the laryngeal region.
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Nasal deposition efficiency is defined as the ratio of the
deposited particles in nasal cavity to the total number
entering through nostril. It is an important parameter
characterizing nasal filtering efficiency. Figure 10a
presents the current simulation result and the comparison
with literature data [35, 52–55]. In the nano range
(d < 100 nm), nasal deposition monotonically decreased
with increase of particle size and the current simula-
tion agreed well with experimental data. Observed
variations, within tolerance of accuracy, were due to
the experimental scattering, geometry variation be-
tween inhalation subjects, and variation in particle
inhalation profiles (far field versus nostril, [56]). Based
on the simulation, nasal and laryngeal deposition, as a
function of flow rate Q (m3/s) and particle diffusivity
D (m2/s) were developed (Table 2). We find that the
correlation D0.510/Q0.318 provided the best curve fit
for the sampled data for breathing rates of 3 to 12 L/min
and particle sizes from 1 to 100 nm in developing the
empirical equations (Fig. 10a and b). Similar trends were
reported in prior studies, e.g. experiments of Cheng
(2003) and simulations from Xi et al. (2008) with the nasal
deposition data conforming to D0.510/Q0.280 and D0.500/
Q0.125 respectively [35, 57]. The empirical equations are
given as:
DEnasal ¼ 1−0:9793e−36:51
D0:510
Q0:318
 
 100 ð25Þ
DElaryngeal ¼ 1−0:9604e−10:73
D0:510
Q0:318
 
 100 ð26Þ
In Eq. (26), the regional laryngeal deposition efficiency is
defined as the ratio of the deposited particles in laryngeal
region to the total number that entered the region. It is
worth to note that Eq. (26) applies to an air flow rate up
P
ar
tic
le
 #
/c
m
3
0
5000
10000
15000
20000
25000
a
9:30am
11:00am
14:30pm
%
 In
cr
ea
se
0
2,000
4,000
6000
8000
10000b
Particle Size Group (nm)
5-10 10-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90-98
P
ar
tic
le
 #
/c
m
3
0
1000
2000
3000
4000c
12:00am - Background
Fig. 6 Increase of the ultrafine particle number concentration due to the production activities: a particle number increase from the background;
b percentage of particle number increase from the background
Tian et al. Particle and Fibre Toxicology  (2017) 14:24 Page 10 of 18
to 12 L/min. Beyond that, laryngeal induced turbulence
start to form which enhances the laryngeal deposition.
Particle dosimetry in human upper airways in the
machine shop
Substitute Eqs. (25) and (26) into Eq. (21), particle number
dosimetry in human upper airways can be obtained as:
Dosenasal numer ¼
Zt2
t1
Zd2
d1
n d; r!; t	 
DEnasal
100
d dð Þdt
¼
Zt2
t1
Zd2
d1
n d; r!; t	 

 1−0:9793e
−36:51
D0:510
Q0:318
0
BBB@
1
CCCAd dð Þdt
ð27Þ
Doselaryngeal number ¼
Zt2
t1
Zd2
d1
n d; r!; t	 

 1−DEnasal
100
0
@
1
A DElaryngeal
100
0
@
1
Ad dð Þdt
¼
Zt2
t1
Zd2
d1
n d; r!; t	 

 0:9793e
−36:51
D0:510
Q0:318
0
BBB@
1
CCCA
 1−0:9604e
−10:73
D0:510
Q0:318
0
BBB@
1
CCCAd dð Þdt
ð28Þ
Similarly, particle dosimetry (by surface area and
mass) can be obtained by substituting Eqs. (25) and
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(26) into Eqs. (22) and (24) accordingly. In the
current study, a log-normal particle size distribution
(n) was detected in the background; however particle
size distribution was transient due to machining
processes during working hours; therefore, a time
averaged particle distribution function based on real
time measurement during the 8-h working period
was used (Eq. (12)).
Figure 11 shows the measured particle distribution
by SMPS during production and with the background
concentration. Fitted equations shown in Fig. 11 are
given as:
Table 1 Airflow rate and Reynolds number
Airflow rate (L/min) Reynolds number
3 183
5 305
7.5 458
10 610
12 732
Fig. 8 Stream-wise and axial air flow pattern in the nasal and upper airways at selected locations
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n dð Þ ¼ a1⋅eb1⋅d þ c1⋅ed1⋅d
Here
a1 ¼ 3197 b1 ¼ ‐0:03849
c1 ¼ 130:7 d1 ¼ 0:006897
ð29Þ
and
a1 ¼ 1792 b1 ¼ ‐0:1035
c1 ¼ 0:7465 d1 ¼ 0:03032
ð30Þ
Eqs. (29) and (30) give the coefficients for particle size
distribution function during production (8-h working
period) and at mid-night (background) respectively.
Based on the SMPS measurement (Eq. (29)), human
upper airway dosimetry in the WEDM machine shop
(d = 5.52 - 98.2 nm) was calculated and presented in
Table 3. The dosages were based on an 8 h period
covering breathing rates of 3 to 12 L/min. Particle
penetration, closely related to deep lung dosimetry,
was also provided.
Table 3 showed a strong monotonic increase in human
upper airway dosage (of inhaled nanoparticles) with
airflow rate across all metrics. This is simply the result
of an increased particle exposure due to larger air
exchange. The slight decrease in particle deposition at
higher flow rate in diffusion region (Eqs. (25) and (26))
was insignificant to the actual dosimetry. While nasal
cavity had a higher “number” dosage than laryngeal,
surprisingly, particle mass and surface area dosages in
laryngeal were higher than that in the nasal cavity. This
difference was overlooked by traditional airway depos-
ition studies where real particle concentration and size
distribution were not available. Further examination
showed that the slight higher deposition rate of larger
sized particles in laryngeal was the cause. For example,
at breathing rate of 12 L/min, the deposition efficiencies
for 70 nm particles are 3.63% in the nasal and 4.37% in
laryngeal region respectively. This implied the mass/
surface carrying particles (larger in size) were more
Fig. 10 Comparison of nasal deposition efficiencies: a nasal deposition efficiencies (Q = 10 L/min); b nasal deposition equation; c laryngeal
deposition equation
a b
c
d
Fig. 9 Particle deposition pattern in the nasal and laryngeal region (Q = 10 L/min): a nasal and laryngeal region (3D); b nasal cavity – left
(unwrapped 2D); c nasal cavity – right (unwrapped 2D); d laryngeal region (unwrapped 2D)
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likely to pass through the nasal cavity, deposit in high
impact region (eg. Laryngeal), or penetrate deep into
the lung. It should be noted that empirical fitting
could contribute to the increased laryngeal deposition,
as a slight under prediction in the nasal and over
prediction in the laryngeal region were observed with
the fittings (Fig. 10b and c) for low diffusivity parti-
cles at low breathing rate (Q = 3 and 5 L/min).
Further research is needed in studying the transition
region particle deposition, which is extremely low
and sensitive to the various transport mechanisms.
Here “transition region” refers to the particle size
range where the dominant particle transport mech-
anism changes from Brownian diffusion to inertia,
suggested by extremely low particle diffusivity and
inertia during the transition phase. More details
can be found in the work of Tian and Ahmadi
(2007) [58].
Figure 12 compared the percentage of the dosage
(number, mass and surface area) in human upper airway
in the WEDM machine shop. Nasal, laryngeal, and the
penetration rate (an implication of the deep lung dosage)
were considered. Clearly shown in Fig. 12, majority of
the particles (d = 5.52 – 98.2 nm) penetrated the nasal
and upper airway. Nasal barrier was most effective in
reducing particle number intake; however least efficient
in trapping mass carrying particles. On the other
hand, laryngeal region consistently filtered out
number/mass/surface particles in all evaluated met-
rics. Breathing rate had minimum influence on rela-
tive dosimetry. The laryngeal region was the least
sensitive to breathing rate, while nasal dosage in
particle number count was the most affected by
breathing rate.
To examine the effect of production, Table 4 displayed
the human upper airway dosimetry with the measured
background concentration during 8 h in the working day
(d = 5.52 - 98.2 nm). As expected, background dosage
estimated from nanoparticle concentration at midnight
was significantly lower than the dosage estimated from
nanoparticle concentration during working hours (Table
3). To quantify the difference, Fig. 13 presented the per-
centage increase of the airway doses in the machine
shop with respect to the background concentration at a
breathing rate of 12 L/min. A remarkable 3100%
increase in mass dosage was observed in the laryngeal
region, while an even higher percentage increase was
seen for the penetrated dose. Meanwhile, a 2664%
increase was detected in the nasal cavity. 1626 to 2633%
dose increase in surface area, and 451 to 752% dose
increase in number was seen respectively. Overall, mass
dosage was the most enhanced, and the WEDM produc-
tion activity had the most profound effects to particle
dosage across all regions in all metrics, especially in the
laryngeal and downstream airways.
Discussion
The combined experimental and numerical study showed
an astonishing enhancement of human airway dosage as a
result of the electrical discharge wire-cutting in the
machine shop. At a breathing rate of 12 L/min during a
typical 8 h shift, mass dosages to the nasal and laryngeal
regions were increased from 0.06 μg to 1.69 μg, and
0.11 μg to 3.42 μg, or 28 and 31 folds respectively. At the
same time, mass dosage penetrated deep into the lung was
increased from 2.28 μg to 74.85 μg or 33 folds, implying a
significant increase of exposure risks to the lower respira-
tory airways. Though at a relatively milder scale, enhance-
ment of the surface area and number dosages due to
production were still significant (6 to 25 folds). Real time
particle number and mass concentration increase from the
background in the WEDM machine shop (Figs. 6 and 7)
Table 3 Human upper airway dosages and penetration of nanoparticles from 5.52 to 98.2 nm in the WEDM in a typical working day
Q (L/min) Number (1010#) Mass (μg) Surface Area (10−5 m2)
Nasal Laryngeal Penetrate Nasal Laryngeal Penetrate Nasal Laryngeal Penetrate
10 3.03 2.04 34.72 1.48 2.87 62.29 6.00 9.99 214.01
12 3.49 2.42 41.84 1.69 3.42 74.85 6.85 11.91 251.24
Table 2 Particle diffusivity D (288.16K)
Particle Diameter (nm) Diffusivity D (m2/s)
1 5.2526E-06
1.5 2.3375E-06
2 1.3165E-06
3 5.8660E-07
5 2.1226E-07
10 5.3757E-08
15 2.4208E-08
20 1.3800E-08
30 6.3013E-09
40 3.6433E-09
50 2.3974E-09
70 1.2935E-09
100 6.8908E-10
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has intrinsic effect to airway dosages, which is dispropor-
tional to the measured concentration increases when look-
ing from different metric perspectives. This finding implies
that a pure number or mass concentration recommenda-
tion on the exposure limit at workplace is insufficient. A
particle size distribution, together with the deposition equa-
tions (eg. Eqs. (25) and (26)), is critical to recognize the
actual exposure risks. In addition, human inhalation
dosimetry is extremely sensitive to real time particle
concentration and size distribution. Averaged particle
concentration over 24-h period will inevitably misrep-
resent the sensible information critical for realistic
inhalation risk assessment.
Currently, the most stringent recommendations for
ultrafine particle exposure are from National Institute
for Occupational Safety and Health (NIOSH, USA) and
German Institute for Occupational Safety and Health of
the German Social Accident Insurance (IFA). According
to NIOSH (2011), the exposure limit for ultrafine titan-
ium dioxide particles (d ≤ 100 nm) is recommended not
exceeding 0.3 mg/m3 in normal working conditions. IFA
(2009) established the benchmark limit for ultrafine par-
ticle (1 nm ≤ d ≤ 100 nm, density ≤ 6000 kg/m3) con-
centration at workplace below 40,000 particles/cm3.
Based on the current measurement, an averaged mass
concentration of 0.013881 mg/m3 and number concen-
tration of 82,884 particles/cm3 were detected in the
WEDM machine shop during working hours. Therefore
the working condition met the specification of NIOSH;
however failed that of the IFA.
As shown in Fig. 13, human airway dosimetry in
number, mass and surface area varied significantly. A
complete inhalation risk assessment requires the know-
ledge of toxicity mechanisms in response to each
individual metric. For example, a recent study [59]
suggested that surface area is the biologically most ef-
fective dose metric for nanoparticle lung toxicity.
Currently, there is no surface based exposure standard.
All recommendations of exposure limits for ultrafine
nanoparticles (d ≤ 100 nm) are either on the total mass
or number concentrations. Moreover, effects of the par-
ticle size distribution and the implication to regional
airway dosages, critical for inhalation risk assessment,
are not included. Further improvements in these areas
are needed.
Conclusions
The combined experimental and numerical study is
the first to establish a realistic exposure condition to
calculate the actual particle dosimetry (in mass, num-
ber and surface area) by using deposition equations
developed through inhalation modeling in a physiolo-
gically realistic nasal and upper airway replica. It was
found out that particle size distribution carries very
Fig. 12 Human upper airway dosage and penetration percentage in the WEDM machine shop: a number dosage; b mass dosage; c surface
area dosage
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important information in determining human airway
dosimetry, and critical for inhalation exposure risk
assessment. Together with the deposition equations,
powerful and accurate prediction of regional dosages
with respect to the various dose metrics (e.g. number,
mass, and surface area) can be made.
An astonishing enhancement of human airway dos-
ages in the WEDM machine shop was detected by the
combined experimental and numerical study. Up to 33
folds in mass, 27 folds in surface area and 8 folds in
number doses, penetrating to deeper airways, were
detected compared to the background dosimetry. The
real time particle concentration measurement showed
substantial emission of nano-pollutants by WEDM
machining activity, and the combined experimental and
numerical study provided extraordinary details on
human inhalation dosimetry. It was found out that
human inhalation dosimetry is extremely sensitive to
real time particle concentration and size distribution.
Averaged particle concentration over 24-h period will
inevitably misrepresent the sensible information critical
for realistic inhalation risk assessment. In the WEDM
machine shop, nanoparticle number concentration is
dominated by the extremely small scales (d ≤ 30 nm)
while mass and surface area concentration is dominated
by larger scales (d ≥ 60 nm). Nasal barrier is most
effective in reducing particle number intake; however least
efficient in catching mass carrying particles. Laryngeal re-
gion is consistent in catching particles in all evaluated
metrics (number, mass and surface). Majority of the
particles (>84% in number, 92% in mass and surface area)
(d = 5.52 – 98.2 nm) penetrate into deeper airways.
Human upper airway dosages monotonically increase with
the breathing rate as a result of the increased particle
exposure due to larger air exchange.
Human airway dosimetry in number, mass and sur-
face area varies significantly. A complete inhalation risk
assessment requires the knowledge of toxicity mecha-
nisms in response to each individual metric. A pure
number or mass concentration recommendation on the
exposure limit at workplace is insufficient. A particle
size distribution, together with the deposition equa-
tions, is critical to recognize the actual exposure risks.
For ultrafine nanoparticles (d ≤ 100 nm), all current
exposure limit recommendations are either on the total
mass or number concentrations, and effects of the
particle size distribution and the implication to regional
airway dosages, critical for inhalation risk assessment,
are not included. Further improvements in these areas
are needed.
Fig. 13 Human airway dosage increase due to production over 8-h shift (Q = 12 L/min)
Table 4 Human upper airway dosages and penetration of nanoparticles from 5.52 to 98.2 nm with background concentration
during 8 h in a day
Q (L/min) Number (1010#) Mass (μg) Surface Area (10−5 m2)
Nasal Laryngeal Penetrate Nasal Laryngeal Penetrate Nasal Laryngeal Penetrate
10 0.55 0.29 4.07 0.05 0.09 1.89 0.35 0.40 7.83
12 0.63 0.34 4.92 0.06 0.11 2.28 0.40 0.48 9.42
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